Login to Your Account

In-Licensing Deals Continue to Power the China Market

By Shannon Ellis
Staff Writer

Wednesday, September 4, 2013
The year 2013 is emerging as a banner one for East-West partnerships among biotech companies. More Western biopharmas with innovative capability and patented molecules in need of development are partnering with local companies in China to tap the potential of the market. The result is a 20 percent to 30 percent annual increase in the number of partnering deals.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription